Medical News

RSS

Biotage announces global launch of Syro Wave microwave and parallel peptide synthesizer

Biotage, a leading supplier of tools and technology for medicinal and analytical chemistry, today announced the eagerly awaited global launch of the Syro Wave™; their new microwave and parallel peptide synthesizer. The Syro Wave™ is a result of the joint development project announced last year between Biotage and MultiSynTech. It combines the proven performance of the established MultiSynTech robotic synthesizer with Biotage microwave technology.

18 Feb 2010

Combination therapy that delays nursing home admission for AD earns 43% patient share in U.S. and 30% in Europe

Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, for the treatment of moderate to severe Alzheimer's disease, a combination therapy that delays nursing home admission at 19 months would earn 43 percent patient share, according to surveyed U.S. neurologists. In comparison, in Europe, such an agent would earn a slightly lower patient share of 30 percent, according to surveyed European neurologists. This lower share estimate is possibly a result of higher price sensitivity of European markets.

18 Feb 2010

Clarion Care develops healthcare software solution to reduce deficit by 42%

As Washington state government considers difficult tax increases and searches for ways to cut spending, Clarion Care, an innovative company, has developed a healthcare software solution that can reduce the deficit by 42%.

18 Feb 2010

Easier walking for amputees: Artificial foot that recycles energy

An artificial foot that recycles energy otherwise wasted in between steps could make it easier for amputees to walk, its developers say.

18 Feb 2010

Deaf and hard-of-hearing patients seeking treatment at OIP to receive interpreters for effective communication

Patients who are deaf or hard-of-hearing, who seek treatment at the Orthopedic Institute of Pennsylvania, will receive qualified interpreters when needed for effective communication as required by federal law under a Settlement Agreement reached with the U.S. Department of Health and Human Services.

18 Feb 2010

Nautic Partners completes recapitalization of HPS in partnership with management

Nautic Partners, LLC, a private equity firm with more than $2.5 billion of capital under management, today announced that it has completed a recapitalization of Healthcare Payment Specialists, LLC (“HPS”) in partnership with management. HPS is a provider of payment and reimbursement solutions to hospitals and other healthcare systems.

18 Feb 2010

Training birth attendants in essential newborn-care techniques can reduce perinatal deaths

New findings in a study led by the director of the University of Alabama at Birmingham (UAB) Division of Neonatology show that that training birth attendants in essential newborn-care techniques reduced stillbirths by more than 30 percent - and potentially could save as many as 1 million lives worldwide each year.

18 Feb 2010

State-of-the-art review of stereological methods for lung morphometry

The ATS and the European Respiratory Society have issued official standards for the quantitative assessment of lung structure.

18 Feb 2010

Training in newborn care and resuscitation to birth attendants increases likelihood of baby's survival

In developing countries, where millions of babies die in the womb or soon after birth, research has shown that providing training in newborn care and resuscitation to birth attendants significantly increases the likelihood of a baby's survival.

18 Feb 2010

AdvanSource Biomaterials reports 2.9% decrease in third-quarter revenue

AdvanSource Biomaterials Corporation, a leading developer of advanced polymer materials for a broad range of medical devices, today announced financial results for its fiscal 2010 third quarter ended December 31, 2009.

18 Feb 2010

Upp Technology adds Vaccine Provider Registration System to irms software suite

Upp Technology, a leader in public health software solutions, announced today at the Public Health Preparedness Summit, that it has enhanced its suite of irms software with the addition of the irms Vaccine Provider Registration System. The new provider management solution is already running in multiple states and the company expects to announce the deployment of this system in another four states within the first quarter of 2010.

18 Feb 2010

Pfizer Canada accepts entries for seventh round of competition for Pfizer CVRAP

Pfizer Canada is currently accepting entries for its seventh round of competition for the Pfizer Cardiovascular Research Awards program (CVRAP). The program, first launched in October 2005, was developed to fund and support independent cardiovascular research in Canada.

18 Feb 2010

Detroit home health agency owner pleads guilty over Medicare fraud

Detroit-area resident Muhammad Shahab pleaded guilty today for his role in organizing a Detroit-area home health care fraud scheme, announced Assistant Attorney General Lanny Breuer of the Criminal Division; U.S. Attorney for the Eastern District of Michigan Barbara L. McQuade; Special Agent in Charge Andrew G. Arena of the FBI's Detroit Field Office; and Special Agent in Charge Lamont Pugh III of the U.S. Department of Health and Human Services, Office of Inspector General's (HHS-OIG), Chicago Regional Office.

18 Feb 2010

Signaling protein has key role in fighting bacterial infection and inflammation in intestinal tract: Study

A signaling protein that is key in orchestrating the body's overall immune response has an important localized role in fighting bacterial infection and inflammation in the intestinal tract, according to a study by UC San Diego School of Medicine investigators, published in the journal Cell Host and Microbe.

18 Feb 2010

RiskMetrics questions Novartis merger proposal

The Alcon Independent Director Committee (the “Committee”) of Alcon, Inc. today announced that RiskMetrics Group, Inc., a global leader in risk management, corporate governance and financial research and analysis, has raised concerns about the adequacy of the merger proposal by Novartis AG (“Novartis”) to Alcon’s minority shareholders and the legality of any attempt by Novartis to unilaterally impose a full takeover of Alcon.

18 Feb 2010

Researcher develops acoustic resonant sensor that can test bodily fluids for variety of diseases

What if it were possible to go to the store and buy a kit to quickly and accurately diagnose cancer, similar to a pregnancy test? A University of Missouri researcher is developing a tiny sensor, known as an acoustic resonant sensor, that is smaller than a human hair and could test bodily fluids for a variety of diseases, including breast and prostate cancers.

18 Feb 2010

Gilead Sciences’ “Quad” regimen for HIV exhibits antiretroviral activity comparable to Atripla

Gilead Sciences, Inc. announced Phase II clinical trial results today showing that its investigational fixed-dose single-tablet “Quad” regimen of elvitegravir, GS 9350 (cobicistat) and Truvada® (emtricitabine and tenofovir disoproxil fumarate) for the treatment of HIV infection exhibited antiretroviral activity comparable to that of Atripla® (efavirenz 600 mg/ emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg).

18 Feb 2010

Keystone Health increases access to healthcare with ARRA grants: Secretary of Health commends

Secretary of Health Everette James commended Keystone Health for increasing access to healthcare with grants from the American Recovery and Reinvestment Act during a groundbreaking ceremony today at the facility's main campus in Chambersburg.

18 Feb 2010

AHA Scientific Statement: Only 33% of annual PCIs are performed in women

President Clinton’s stent surgery brought new focus to America’s number-one killer, but it did little to expose the bias that is often present when women seek treatment for a heart attack.

18 Feb 2010

HPV DNA testing vital in identification of cervical cancer

Roche Molecular Systems, Inc. announced today that preliminary data from its ATHENA (Addressing THE Need for Advanced HPV Diagnostics) trial support the importance of screening for human papillomavirus (HPV) genotypes that put women at highest risk for developing cervical cancer. ATHENA is a prospective, double-blind, multi-centered, 47,000-patient, U.S.-registration trial designed to demonstrate the effectiveness of HPV detection as part of a cervical cancer screening program.

18 Feb 2010

Medical News

Biotage announces global launch of Syro Wave microwave and parallel peptide synthesizer

Combination therapy that delays nursing home admission for AD earns 43% patient share in U.S. and 30% in Europe

Clarion Care develops healthcare software solution to reduce deficit by 42%

Easier walking for amputees: Artificial foot that recycles energy

Deaf and hard-of-hearing patients seeking treatment at OIP to receive interpreters for effective communication

Nautic Partners completes recapitalization of HPS in partnership with management

Training birth attendants in essential newborn-care techniques can reduce perinatal deaths

State-of-the-art review of stereological methods for lung morphometry

Training in newborn care and resuscitation to birth attendants increases likelihood of baby's survival

AdvanSource Biomaterials reports 2.9% decrease in third-quarter revenue

Upp Technology adds Vaccine Provider Registration System to irms software suite

Pfizer Canada accepts entries for seventh round of competition for Pfizer CVRAP

Detroit home health agency owner pleads guilty over Medicare fraud

Signaling protein has key role in fighting bacterial infection and inflammation in intestinal tract: Study

RiskMetrics questions Novartis merger proposal

Researcher develops acoustic resonant sensor that can test bodily fluids for variety of diseases

Gilead Sciences’ “Quad” regimen for HIV exhibits antiretroviral activity comparable to Atripla

Keystone Health increases access to healthcare with ARRA grants: Secretary of Health commends

AHA Scientific Statement: Only 33% of annual PCIs are performed in women

HPV DNA testing vital in identification of cervical cancer

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Latest News